Differentiation between Merkel cell carcinoma and malignant melanoma: An immunohistochemical study

Citation
Gj. Kontochristopoulos et al., Differentiation between Merkel cell carcinoma and malignant melanoma: An immunohistochemical study, DERMATOLOGY, 201(2), 2000, pp. 123-126
Citations number
18
Categorie Soggetti
Dermatology
Journal title
DERMATOLOGY
ISSN journal
10188665 → ACNP
Volume
201
Issue
2
Year of publication
2000
Pages
123 - 126
Database
ISI
SICI code
1018-8665(2000)201:2<123:DBMCCA>2.0.ZU;2-O
Abstract
Background Although Merkel cell carcinoma (MCC) exhibits specific clinical and histologic features, differentiation from other cutaneous neoplasms, su ch as lymphoma, metastatic oat cell carcinoma and malignant melanoma (MM), may sometimes be difficult. Objective: The aim of our study was to immunohi stochemically differentiate MCC from MM. Methods: Paraffin sections from 6 cases of primary MCC and 6 cases of primary MM were investigated. For immun ostaining, the APAAP method was used. Results: Neuron-specific enolase was positive in all cases of MCC, as well as in 2 cases of MM. Marked positivit y for cytokeratins 18, 20 and chromogranin A was observed in the MCC group, whereas a complete absence of expression of these th ree markers was noted in the MM group. Immunostaining with HMB45 and NKI/C3 was positive in all cases of MM and negative in all cases of MCC. S-100 protein was positive in all but 1 case of MM. In contrast, only 1 case of MCC reacted with S-100 p rotein. Conclusion: Our results underline the role of immunohistochemistry in the diagnosis and differential diagnosis of MCC. In particular, the comb ination of neuron-specific enolase, cytokeratins 18, 20 and chromogranin A positivity for MCC and HMB45, NKI/C3 and S-100 protein positivity for MM is of great value in the distinction between these two cutaneous neoplasms. C opyright (C) 2000 S. Karger AG, Basel.